Payer Decision-Making for Next Generation Sequencing-Based Genetic Tests: Insights from cell-free DNA prenatal genetic screening

PURPOSE: Cell-free DNA (cfDNA) prenatal screening tests have been rapidly adopted into clinical practice, in part due to positive insurance coverage. We evaluated the framework payers used in making coverage decisions to describe a process that should be informative for other sequencing tests. METHO...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Genet Med
Main Authors: Dervan, Andrew P., Deverka, Patricia A., Trosman, Julia R., Weldon, Christine B., Douglas, Michael P., Phillips, Kathryn A.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362360/
https://ncbi.nlm.nih.gov/pubmed/27657682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2016.145
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares